Q2 2023 · 13F-HR
Integral Health Asset Management, LLCholdings as filed
Filed 2023-08-11 · accession 0001420506-23-001479
$807.6M
Reported value
73
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 125523100 | CI | THE CIGNA GROUP | $50.5M | 6.25% | 180,000 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $43.7M | 5.41% | 300,000 | Common | SOLE |
| 670100955 | — | NOVO-NORDISK A S | $40.5M | 5.01% | 250,000 | PUT | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $33.4M | 4.14% | 103,000 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $30.8M | 3.81% | 72,000 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $25.2M | 3.12% | 466,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $21.2M | 2.63% | 650,000 | Common | SOLE |
| 216648402 | — | COOPER COS INC | $19.9M | 2.47% | 52,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $18.9M | 2.34% | 232,000 | Common | SOLE |
| 714046109 | RVTY | REVVITY INC | $16.6M | 2.06% | 140,000 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $15.6M | 1.93% | 40,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $15.3M | 1.89% | 300,000 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $14.9M | 1.84% | 220,000 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $14.7M | 1.83% | 412,000 | Common | SOLE |
| 436440101 | HO1 | HOLOGIC INC | $14.2M | 1.75% | 175,000 | Common | SOLE |
| 532457108 | LLY | LILLY ELI & CO | $14.1M | 1.74% | 30,000 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $13.5M | 1.67% | 200,000 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $13.5M | 1.67% | 100,000 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $13.3M | 1.65% | 30,000 | Common | SOLE |
| 80810D103 | SDGR | SCHRODINGER INC | $13.2M | 1.64% | 265,000 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $12.7M | 1.57% | 450,000 | Common | SOLE |
| 37733W204 | GSK | GSK PLC | $12.5M | 1.54% | 350,000 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $12.3M | 1.52% | 36,000 | Common | SOLE |
| 75615P103 | — | REATA PHARMACEUTICALS INC | $12.2M | 1.51% | 120,000 | Common | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $12.1M | 1.50% | 40,000 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $12.0M | 1.49% | 50,000 | Common | SOLE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $11.9M | 1.48% | 72,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $11.8M | 1.47% | 730,000 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $11.5M | 1.42% | 350,000 | Common | SOLE |
| 86881A100 | SGRY | SURGERY PARTNERS INC | $11.2M | 1.39% | 250,000 | Common | SOLE |
| 66987V109 | NVS | NOVARTIS AG | $10.4M | 1.29% | 103,000 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $10.3M | 1.28% | 445,000 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $10.3M | 1.28% | 30,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $9.9M | 1.22% | 52,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $9.5M | 1.18% | 356,000 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $9.0M | 1.12% | 155,000 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $9.0M | 1.11% | 142,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $8.9M | 1.10% | 284,000 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $8.8M | 1.09% | 700,000 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $8.4M | 1.04% | 206,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $8.3M | 1.02% | 88,000 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $7.5M | 0.93% | 1,000,000 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $7.3M | 0.90% | 62,000 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $7.1M | 0.88% | 174,000 | Common | SOLE |
| 53228F101 | LFST | LIFESTANCE HEALTH GROUP INC | $7.1M | 0.87% | 773,000 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $7.0M | 0.87% | 80,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $6.6M | 0.81% | 72,000 | Common | SOLE |
| 761330109 | RVNCEUR | REVANCE THERAPEUTICS INC | $6.3M | 0.78% | 250,000 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $6.2M | 0.77% | 250,000 | Common | SOLE |
| 825704109 | SIBN | SI-BONE INC | $6.1M | 0.76% | 227,000 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $5.6M | 0.70% | 100,000 | Common | SOLE |
| 74276R102 | PRVA | PRIVIA HEALTH GROUP INC | $5.2M | 0.65% | 200,000 | Common | SOLE |
| 29415F104 | NVST | ENVISTA HOLDINGS CORPORATION | $5.1M | 0.63% | 150,000 | Common | SOLE |
| 87918A105 | TDOC | TELADOC HEALTH INC | $5.1M | 0.63% | 200,000 | Common | SOLE |
| 03073E105 | COR | AMERISOURCEBERGEN CORP | $5.0M | 0.62% | 26,000 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $4.9M | 0.60% | 387,000 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $4.4M | 0.54% | 598,000 | Common | SOLE |
| 227483104 | CCRN | CROSS CTRY HEALTHCARE INC | $4.4M | 0.54% | 155,000 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $4.3M | 0.54% | 50,000 | Common | SOLE |
| 24906P109 | XRAY | DENTSPLY SIRONA INC | $4.0M | 0.50% | 100,000 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $3.9M | 0.48% | 36,000 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $3.8M | 0.47% | 80,000 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $3.6M | 0.44% | 52,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $3.3M | 0.40% | 70,000 | Common | SOLE |
| 931427908 | — | WALGREENS BOOTS ALLIANCE INC | $2.8M | 0.35% | 100,000 | CALL | SOLE |
| N90064901 | — | UNIQURE NV | $2.3M | 0.28% | 200,000 | CALL | SOLE |
| 868459108 | SUPN | SUPERNUS PHARMACEUTICALS INC | $2.3M | 0.28% | 75,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $2.1M | 0.26% | 52,000 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $2.1M | 0.26% | 75,000 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $2.0M | 0.25% | 412,000 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $2.0M | 0.25% | 200,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $1.6M | 0.20% | 180,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $697,500 | 0.09% | 62,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.